Importance of infusion volume and pump characteristics in extended administration of ß-lactam antibiotics.
Claus
Barbara
B
Buyle
Franky
F
Robays
Hugo
H
Vogelaers
Dirk
D
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004333:Drug Administration Routes; D006801:Humans; D000077731:Meropenem; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D010878:Piperacillin / Q000008:administration & dosage / Q000627:therapeutic use; D000078142:Tazobactam; D013845:Thienamycins / Q000008:administration & dosage / Q000627:therapeutic use; D047090:beta-Lactams / Q000008:administration & dosage* / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D013845:Thienamycins; D047090:beta-Lactams; D010397:Penicillanic Acid; D000077731:Meropenem; D000078142:Tazobactam; D010878:Piperacillin
Contemp Nurse. 2004 Oct;17(3):264-73
15551677
Clin Infect Dis. 2007 Feb 1;44(3):357-63
17205441
Crit Care Med. 2009 Jun;37(6):2071-8
19384201
Antimicrob Agents Chemother. 2010 Jan;54(1):460-5
19858253
Diagn Microbiol Infect Dis. 2009 Jun;64(2):236-40
19500529